UQD

7.

Zimbabwe’s new Global Fund grants for TB/HIV are clearly aligned to the country’s epi profile and its national strategic plans, TRP says

17 Oct 2017
Grants include a strong focus on interventions targeting key populations

In their recommendation to the Board on Zimbabwe’s TB/HIV funding request, the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) commented favorably on Zimbabwe’s inclusion of interventions to address barriers related to human rights and gender, and its focus on key populations for HIV, TB and STI care and treatment.

7.

The UQD register is now available on the Global Fund’s website

19 Sep 2017
In 2014-2016, almost $1 billion in interventions from the register were funded

The Global Fund is providing access to its Register of Unfunded Quality Demand via its website. Two databases in Excel format are available, one for 2014-2016 and one for 2017-2019. The databases can be downloaded here.

2.

$10.3 billion is available for the 2017-2019 allocations to countries

17 Nov 2016
Includes $1.1 billion in unutilized funds from the 2014-2016 allocations

The amount of money available for country allocations for 2017-2019 is $10.3 billion. This amount includes $1.1 billion in unutilized funds from the 2014-2016 allocation period. See the table for details on how the final amount was calculated.

Table: Calculation of amount available for allocations to countries in 2017-2019 ($US)

10.

Board approves another batch of NFM grants

6 Sep 2016
Fourteen country grants will receive $180 million; four regional grants will get $25 million
Domestic financing represents between 9% and 80% of total resources for the next implementation period, depending on the grant

In August 2016, the Global Fund Board approved $180 million in funding for 14 grants emanating from concept notes submitted by 11 countries. Of the $180 million, $60 million represented new money; the balance was existing funding that had been approved prior to the new funding model (NFM) but was nevertheless included in the NFM allocations to countries.

8.

Board approves funding to extend shortened grants

1 Aug 2016
$388 million awarded to grants in five countries

In July 2016, the Global Fund Board approved $388 million in funding for six shortened grants to allow them to continue to provide services from the original end date of their grants to the end of 2017. Of the $388 million, $383 million is new funding. It comes from the $700 million that the Finance and Operational Performance Committee said in March 2016 was available for portfolio optimization.

3.

Another 18 grants okayed for funding

18 Jul 2016
$364 million approved for 12 countries

In July 2016, the Global Fund Board approved $364 million in funding for 18 grants emanating from concept notes submitted by 12 countries. Of the $364 million, $152 million represented new money; the balance was existing funding that had been approved prior to the new funding model (NFM) but was nevertheless included in the NFM allocations to countries.

7.

Funding of $164 million approved for 13 grants in 11 countries

7 Jun 2016
The largest award went to a Niger malaria grant
Sierra Leone received $11 million in incentive funding for its HSS grant

In May 2016, the Global Fund Board approved $164 million in funding for 13 grants emanating from concept notes submitted by 11 countries. Of the $164 million, $114 million represented new money; the balance was existing funding that had been approved prior to the new funding model but was nevertheless included in the NFM allocations to countries.

8.

Board approves funding to extend the duration of two shortened grants in DRC and Mozambique

10 May 2016
Funding also approved from the 2014-2016 allocations for TB/HIV grants to Liberia

For the first time, the Board has approved additional funding for two shortened grants. The decision came on 14 March 2016, the same day that that the Board approved additional funding for two TB/HIV grants for Liberia from the 2014-2016 allocations.

Shortened grants

6.

Additional information on March funding approvals

19 Apr 2016

On 5 April 2016, GFO reported that $630 million in funding had been approved by the Board. In this article, we provide additional details on the funding awards to some of the countries.

7.

New TB/HIV funding for South Africa to be implemented by eight PRs

19 Apr 2016
Focus is on key populations and high impact interventions

On 5 April 2016, GFO reported that $630 million in funding was approved by the Board in March. Below, we provide details on the award to South Africa. (See separate GFO article on details of the awards to several other countries.)

Pages

Subscribe to UQD